Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD-positive blood products in trauma.

MLA

Andrews, Jennifer, et al. “Weighing the Risk of Hemolytic Disease of the Newborn versus the Benefits of Using of RhD-Positive Blood Products in Trauma.” Transfusion, vol. 63 Suppl 3, May 2023, pp. S4–9. EBSCOhost, https://doi.org/10.1111/trf.17352.

APA

Andrews, J., Josephson, C. D., Young, P., Spinella, P. C., & Yazer, M. H. (2023). Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD-positive blood products in trauma. Transfusion, 63 Suppl 3, S4–S9. https://doi.org/10.1111/trf.17352

Chicago

Andrews, Jennifer, Cassandra D Josephson, Pampee Young, Philip C Spinella, and Mark H Yazer. 2023. “Weighing the Risk of Hemolytic Disease of the Newborn versus the Benefits of Using of RhD-Positive Blood Products in Trauma.” Transfusion 63 Suppl 3 (May): S4–9. doi:10.1111/trf.17352.